|
Volumn 61, Issue 2, 2006, Pages 135-139
|
Risk assessment of human myelotoxicity of anticancer drugs: A predictive model and the in vitro colony forming unit granulocyte/macrophage (CFU-GM) assay
|
Author keywords
[No Author keywords available]
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
9 AMINOCAMPTOTHECIN;
CAMPTOTHECIN;
CAMPTOTHECIN DERIVATIVE;
EXATECAN;
IRINOTECAN;
TOPOTECAN;
ANIMAL TISSUE;
AREA UNDER THE CURVE;
ARTICLE;
BONE MARROW TOXICITY;
COLONY FORMING UNIT GM;
CONTROLLED STUDY;
HUMAN;
HUMAN TISSUE;
IC 50;
IN VITRO STUDY;
MAXIMUM TOLERATED DOSE;
MOUSE;
NONHUMAN;
RISK ASSESSMENT;
TOXICOLOGY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
AREA UNDER CURVE;
BONE MARROW DISEASES;
CAMPTOTHECIN;
DATA INTERPRETATION, STATISTICAL;
DOGS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
MICE;
NEUTROPENIA;
PREDICTIVE VALUE OF TESTS;
RISK ASSESSMENT;
STEM CELLS;
TUMOR STEM CELL ASSAY;
|
EID: 33644550695
PISSN: 00317144
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (5)
|